脂质代谢在乳腺癌进展过程中的重要作用与机制

doi:10.3760/cma.j.issn.1007-1245.2024.15.002

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (15): 2470-2473.DOI: 10.3760/cma.j.issn.1007-1245.2024.15.002

脂质代谢在乳腺癌进展过程中的重要作用与机制

蔡艺威闫晨名岳林皓王晓红贾中明

滨州医学院附属医院乳腺外科，滨州　256603

收稿日期:2024-01-22 出版日期:2024-08-01 发布日期:2024-09-02
通讯作者: 贾中明，Email：18678325256@163.com
基金资助:
国家自然科学基金（81902702）；山东省自然科学基金（ZR2017LH072）；山东省医药卫生科技发展计划（202104010995）

Important role and mechanism of lipid metabolism in breast cancer progression

Cai Yiwei, Yan Chenming, Yue Linhao, Wang Xiaohong, Jia Zhongming

Department of Breast Surgery, Binzhou Medical University Hospital, Binzhou 256603, China

Received:2024-01-22 Online:2024-08-01 Published:2024-09-02
Contact: Jia Zhongming, Email: 18678325256@163.com
Supported by:
National Natural Science Foundation (81902702); Shandong Natural Science Foundation (ZR2017LH072); Shandong Province Medical and Health Science and Technology Development Plan (202104010995)

摘要/Abstract

摘要：

乳腺癌是起源于乳腺上皮组织的恶性肿瘤，其发病率呈逐年上升趋势。脂质代谢水平和调控作用在肿瘤细胞的增殖、迁移、侵袭、转移和产生耐药性的过程中发挥重要作用。本文从脂质代谢成分（包括脂肪酸、三酰甘油和胆固醇）、脂质代谢信号通路、脂质代谢调控基因3个方面，综述脂质代谢在乳腺癌进展过程中的作用与机制，展望靶向脂质代谢治疗的潜在临床价值，为制定有效的治疗策略和开发代谢靶向药物提供理论参考。

关键词:

乳腺癌, 脂质代谢, 信号通路, 调控基因, 作用机制, 进展

Abstract:

Breast cancer is a malignant tumor originating from breast epithelial tissue, and its incidence rate is increasing year by year. Studies have shown that the level and regulation of lipid metabolism play an important role in the tumor cell proliferation, migration, invasion, metastasis, and development of drug resistance. This paper reviews the role and mechanism of lipid metabolism in the breast cancer progression from three aspects: lipid metabolism components (fatty acids, triglycerides and cholesterol), lipid metabolism signaling pathway, and regulatory genes of lipid metabolism, offers insights into the potential clinical value of targeted lipid metabolism therapy, and provides theoretical references for formulating effective treatment strategies and developing metabolism-targeted drugs.

Key words:

Breast cancer, Lipid metabolism, Signaling pathways, Regulatory genes, Mechanism of action, Progress

蔡艺威闫晨名岳林皓王晓红贾中明.

脂质代谢在乳腺癌进展过程中的重要作用与机制 [J]. 国际医药卫生导报, 2024, 30(15): 2470-2473.

Cai Yiwei, Yan Chenming, Yue Linhao, Wang Xiaohong, Jia Zhongming.

Important role and mechanism of lipid metabolism in breast cancer progression [J]. International Medicine and Health Guidance News, 2024, 30(15): 2470-2473.

参考文献

[1] Barzaman K, Karami J, Zarei Z, et al. Breast cancer: biology, biomarkers, and treatments[J]. Int Immunopharmacol, 2020,84:106535. DOI: 10.1016/j.intimp.2020.106535.
[2] 雷雨蒙,王钦,易玲娜,等. 武汉市社区适龄女性乳腺癌认知度与乳腺自检现状调查[J]. 公共卫生与预防医学,2019,30(3):103-106. DOI:10.3969/j.issn.1006-2483. 2019.03.024.
[3] Hultsch S, Kankainen M, Paavolainen L, et al. Association of tamoxifen resistance and lipid reprogramming in breast cancer[J]. BMC Cancer, 2018,18(1):850. DOI: 10.1186/s12885-018-4757-z.
[4] Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer[J]. Nat Rev Cancer, 2016,16(11):732-749. DOI: 10.1038/nrc.2016.89.
[5] Song L, Liu Z, Hu HH, et al. Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy[J]. Nat Commun, 2020,11(1):5842. DOI: 10.1038/s41467-020- 19694-w.
[6] 沈俊俊,潘月芬,钟丽萍,等. 浸润性乳腺癌的血脂代谢特点及其与分子分型的关系研究[J]. 中国卫生检验杂志,2018,28(19):2352-2355,2358.
[7] Kitahara CM, Berrington de González A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea[J]. J Clin Oncol, 2011,29(12):1592-1598. DOI: 10.1200/JCO.2010.31.5200.
[8] 蒋圣早,陈东祥.血清血脂及载脂蛋白水平与乳腺癌的相关性[J].中国现代医生,2015,53(14):17-20.
[9] 姚宇锋,唐金海,秦建伟. 脂质代谢紊乱对乳腺癌复发转移的影响[J]. 现代肿瘤医学,2011,19(12):2454-2455. DOI:10.3969/j.issn.1672-4992.2011.12.29.
[10] Li P, Lu M, Shi J, et al. Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis[J]. Nat Immunol, 2020,21(11):1444-1455. DOI: 10.1038/s41590-020-0783-5.
[11] 黄赞. 脂质代谢、体质量指数与乳腺癌发生的关系[J]. 中国实用医药,2019,14(27):3-5. DOI:10.14163/j.cnki. 11-5547/r.2019.27.002.
[12] Li X, Liu ZL, Wu YT, et al. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy[J]. Lipids Health Dis, 2018,17(1):91. DOI: 10.1186/s12944-018-0745-1.
[13] Nelson ER. The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer[J]. Mol Cell Endocrinol, 2018,466:73-80. DOI: 10.1016/j.mce.2017.09.021.
[14] Zhao Z, Hao D, Wang L, et al. CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling[J]. Oncogene, 2019,38(12):2076-2091. DOI: 10.1038/s41388-018-0570-z.
[15] 陈妮娜,赵磊,曹邦伟. 胆固醇——乳腺癌风险和预后的预测因子[J]. 肿瘤防治研究,2019,46(9):847-850. DOI:10.3971/j.issn.1000-8578.2019.19.0265.
[16] Gallagher EJ, Zelenko Z, Neel BA, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia[J]. Oncogene, 2017,36(46):6462-6471. DOI: 10.1038/onc.2017.247.
[17] 谢钰德,李志升,李圆,等. 脂肪酸合成酶在乳腺癌治疗抵抗中的研究进展[J]. 广东医学,2023,44(4):519-524. DOI:10.13820/j.cnki.gdyx.20223289.
[18] Nieman KM, Romero IL, Van Houten B, et al. Adipose tissue and adipocytes support tumorigenesis and metastasis[J]. Biochim Biophys Acta, 2013,1831(10):1533-1541. DOI: 10.1016/j.bbalip.2013.02.010.
[19] Luo DX, Tong DJ, Rajput S, et al. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential[J]. Recent Pat Anticancer Drug Discov, 2012,7(2):168-84. DOI: 10.2174/157489212799972918.
[20] 王淼,王欣宇,李鸿铭,等. 脂质代谢在乳腺癌发病中的作用[J]. 生物化学与生物物理进展,2022,49(6):1052-1060. DOI:10.16476/j.pibb.2021.0123.
[21] Gruslova A, McClellan B, Balinda HU, et al. FASN inhibition as a potential treatment for endocrine-resistant breast cancer[J]. Breast Cancer Res Treat, 2021,187(2):375-386. DOI: 10.1007/s10549-021-06231-6.
[22] Rysman E, Brusselmans K, Scheys K, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation[J]. Cancer Res, 2010,70(20):8117-8126. DOI: 10.1158/0008-5472.CAN-09-3871.
[23] 程丽,马颖超,谢富华. 脂肪酸代谢失调影响乳腺癌发展[J]. 赣南医学院学报,2023,43(6):570-576. DOI:10.3969/j.issn.1001-5779.2023.06.004.
[24] 曹林,韩丽,杨明,等. 利用生物信息学分析筛选乳腺癌不良预后的关键基因[J]. 中国医药生物技术,2020,15(4):404-410. DOI:10.3969/j.issn.1673-713X.2020.04.012.
[25] Zhao D, Mo Y, Li MT, et al. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells[J]. J Clin Invest, 2014,124(12):5453-5465. DOI: 10.1172/JCI76611.
[26] Chen M, Lu P, Ma Q, et al. CTNNB1/β-catenin dysfunction contributes to adiposity by regulating the cross-talk of mature adipocytes and preadipocytes[J]. Sci Adv, 2020,6(2):eaax9605. DOI: 10.1126/sciadv.aax9605.
[27] 臧传鑫,刘瑞娟,赵文歌,等. 乳腺癌干细胞相关信号通路及其抑制剂的研究进展[J]. 肿瘤学杂志,2019,25(1):27-31. DOI:10.11735/j.issn.1671-170X.2019.01.B007.
[28] Porstmann T, Santos CR, Griffiths B, et al. A. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth[J]. Cell Metab, 2008,8(3):224-236. DOI: 10.1016/j.cmet.2008.07.007.
[29] 许光亚,王婷,李斌,等. 乳腺癌的靶向治疗研究进展[J]. 中国药物经济学,2021,16(9):125-128. DOI:10.12010/j.issn. 1673-5846.2021.09.027.
[30] Little JL, Wheeler FB, Fels DR, et al. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells[J]. Cancer Res, 2007,67(3):1262-1269. DOI: 10.1158/0008-5472.CAN-06-1794.
[31] Wu X, Qin L, Fako V, et al. Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments[J]. Adv Biol Regul, 2014,54:214-221. DOI: 10.1016/j.jbior.2013.09.004.
[32] Giró-Perafita A, Palomeras S, Lum DH, et al. Preclinical evaluation of fatty acid synthase and EGFR inhibition in triple-negative breast cancer[J]. Clin Cancer Res, 2016,22(18):4687-4697. DOI: 10.1158/1078-0432.CCR-15- 3133.
[33] 吕静,王斌,糜漫天,等.脂质代谢相关基因在乳腺浸润性导管癌中的表达及其意义[J].第三军医大学学报,2010,32(12):1290-1292.DOI:10.16016/j.1000-5404.2010. 12.030.
[34] Clendening JW, Penn LZ. Targeting tumor cell metabolism with statins[J]. Oncogene, 2012,31(48):4967-4978. DOI: 10.1038/onc.2012.6.
[35] Bjarnadottir O, Romero Q, Bendahl PO, et al. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial[J]. Breast Cancer Res Treat, 2013,138(2):499-508. DOI: 10.1007/s10549-013-2473-6.

脂质代谢在乳腺癌进展过程中的重要作用与机制

Important role and mechanism of lipid metabolism in breast cancer progression

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	曾宪虎李明李子龙项旭田慧李惠珠马龙杰方笑丽陈力唐冉. 中西医关于溃疡性结肠炎的研究进展 [J]. 国际医药卫生导报, 2024, 30(9): 1415-1418.
[2]	高雯雯张翔王红尹雁惠. 小肠细菌过度生长的治疗新进展 [J]. 国际医药卫生导报, 2024, 30(9): 1418-1421.
[3]	孙虓刘成霞王娜郝佳慧储琳琳栗成钰. 探讨胃“炎癌转化”中腐胺与巨噬细胞极化的关系 [J]. 国际医药卫生导报, 2024, 30(9): 1426-1429.
[4]	王文斌郭小花郑兆华郭曼孙力. 帕博利珠单抗联合白蛋白紫杉醇与卡培他滨方案治疗进展期胃癌患者的疗效评估 [J]. 国际医药卫生导报, 2024, 30(9): 1430-1434.
[5]	李纯杜巧婷刘令令. 初产妇产后缺乳中西医治疗研究进展 [J]. 国际医药卫生导报, 2024, 30(9): 1446-1449.
[6]	何祥琴杨芳丁国锋. 中成药相关肝损伤研究进展 [J]. 国际医药卫生导报, 2024, 30(9): 1450-1453.
[7]	杨寿娟张海涛崔明丽王建李洋程艳丽. Wnt信号通路在急性心肌梗死中的研究进展 [J]. 国际医药卫生导报, 2024, 30(8): 1291-1296.
[8]	刘志强张翠董文敬刘振孙经武. 心肌纤维化与AMPK-mTOR-ULK1信号通路研究进展 [J]. 国际医药卫生导报, 2024, 30(8): 1297-1300.
[9]	邹皓珍杨佳席哲帆纪瑞董华. 单细胞RNA测序技术在肾病中的研究进展 [J]. 国际医药卫生导报, 2024, 30(8): 1307-1311.
[10]	邵爽郭纪伟孟玮. m⁶A及m⁵C甲基化修饰通过促进细胞增殖与转移影响癌症的发生和发展 [J]. 国际医药卫生导报, 2024, 30(8): 1316-1320.
[11]	赵博李思维邢甜高萍朱宏喆李敏. TRPV1通道在感染性疾病中的研究进展 [J]. 国际医药卫生导报, 2024, 30(7): 1057-1062.
[12]	李孟奇李朋杜刚强孙鸿朔张锴. 长骨骨不连的发病率及手术治疗研究进展 [J]. 国际医药卫生导报, 2024, 30(7): 1062-1066.
[13]	丁嘉雯李娜. ESBLs阳性肺炎克雷伯菌的研究进展 [J]. 国际医药卫生导报, 2024, 30(7): 1071-1074.
[14]	崔启迪孙杉杉陆梅黄燕瑛吕文文. 基于网络药理学和分子对接探讨天花粉治疗肺癌的作用机制 [J]. 国际医药卫生导报, 2024, 30(6): 881-889.
[15]	陈晓琳, 杨贞. HR-HPV载量与宫颈上皮内病变及宫颈癌相关性的研究进展 [J]. 国际医药卫生导报, 2024, 30(6): 932-935.